SCHEMBL6709927

SCHEMBL6709927

CCC(C(=O)Nc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3noc(=O)[nH]3)[nH]c12)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
KCNQ2 O43526 3/20 0.41
HDAC3 O15379 5/20 0.40
HDAC1 Q13547 5/20 0.40
HDAC2 Q92769 5/20 0.40
HDAC4 P56524 3/20 0.40
HDAC7 Q8WUI4 3/20 0.40
HDAC10 Q969S8 3/20 0.40
HDAC11 Q96DB2 3/20 0.40
HDAC8 Q9BY41 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40
HDAC9 Q9UKV0 3/20 0.40
HDAC5 Q9UQL6 3/20 0.40
NCOR2 Q9Y618 2/20 0.39
GRIK1 P39086 1/20 0.39
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NSD2 O96028 1/20 0.36
LMNA P02545 2/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713976 0.91 MAPT (0.43) MAPTKCNQ2HDAC3HDAC1HDAC2
SCHEMBL6710322 0.90 GRIK1 (0.41) MAPTGRIK1MAPK1TDP1NSD2
SCHEMBL6713476 0.89 GRIK1 (0.41) MAPTGRIK1MAPK1TDP1NSD2
SCHEMBL6710195 0.89 MAPT (0.39) MAPTKCNQ2HDAC3HDAC1HDAC2
SCHEMBL6707950 0.88 GRIK1 (0.42) MAPTGRIK1MAPK1TDP1NSD2
SCHEMBL6711613 0.87 CASP3 (0.41) MAPTGRIK1MAPK1TDP1NSD2
SCHEMBL6713760 0.86 GRIK1 (0.42) MAPTGRIK1TDP1NSD2TP53
SCHEMBL6708780 0.86 GRIK1 (0.38) MAPTGRIK1MAPK1TDP1LMNA
SCHEMBL6713262 0.86 GRIK1 (0.41) MAPTGRIK1MAPK1TDP1NSD2
SCHEMBL6713918 0.85 KCNQ2 (0.41) MAPTKCNQ2HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MAPT 4754/4885KCNQ2 2577/4885HDAC3 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.